about
Presenting symptoms of glioma in adults.Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain InjuryA polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction.Outcomes of cranioplasty with synthetic materials and autologous bone grafts.Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.Chronic subdural hematomas in Finnish patients with Huntington's disease.Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers.Injury profiles, demography and representativeness of patients with TBI attending a regional emergency department.A glass fiber-reinforced composite - bioactive glass cranioplasty implant: A case study of an early development stage implant removed due to a late infection.Metabolomics Profiling As a Diagnostic Tool in Severe Traumatic Brain Injury.Paediatric cranial defect reconstruction using bioactive fibre-reinforced composite implant: early outcomes.High angular resolution diffusion-weighted imaging in mild traumatic brain injury.A Systematic Review of the Usefulness of Glial Fibrillary Acidic Protein for Predicting Acute Intracranial Lesions following Head Trauma.Regional brain morphometry in patients with traumatic brain injury based on acute- and chronic-phase magnetic resonance imaging.Quantitative EEG Parameters for Prediction of Outcome in Severe Traumatic Brain Injury: Development Study.Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Are Not Specific Biomarkers for Mild CT-Negative Traumatic Brain Injury.The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.Acute hormonal findings after aneurysmal subarachnoid hemorrhage - report from a single center.Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects.Predictors of primary autograft cranioplasty survival and resorption after craniectomy.Cranioplasty After Severe Traumatic Brain Injury: Effects of Trauma and Patient Recovery on Cranioplasty Outcome.Assessing the depth of dexmedetomidine-induced sedation with electroencephalogram (EEG)-based spectral entropyEstimation of cardiac output in a pharmacological trial using a simple method based on arterial blood pressure signal waveform: a comparison with pulmonary thermodilution and echocardiographic methodsSerum Metabolites Associated with Computed Tomography Findings after Traumatic Brain InjuryFatal traumatic brain injuries during 13 years of successive alcohol tax increases in Finland - a nationwide population-based registry studyDorsal hand vein responses to the α₁-adrenoceptor agonist phenylephrine do not predict responses to the α₂-adrenoceptor agonist dexmedetomidine[Cerebral oedema caused by sodium valproate]Integrative Analysis of Circulating Metabolite Profiles and Magnetic Resonance Imaging Metrics in Patients with Traumatic Brain InjuryA decade of geriatric traumatic brain injuries in Finland: population-based trendsTBIcare Investigators' Response to Papa and Wang (doi: 10:1089/neu.2017.5030): Raising the Bar for Traumatic Brain Injury Biomarker Research: Methods Make a DifferenceStroke hospitalization trends of the working-aged in FinlandRisk Factors for Recurrent Hematoma After Surgery for Acute Traumatic Subdural HematomaA large calvarial bone defect in a child: osteointegration of an implantMachine learning-based dynamic mortality prediction after traumatic brain injuryCorrelation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain InjuryProspective Validation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in AdultsSerum Neurofilament Light Is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain InjuriesEarly Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain InjuryBiomaterial and implant induced ossification: in vitro and in vivo findings
P50
Q30855623-2D4FF235-05AB-4EA9-A607-6459294018D0Q37363452-2F6298C1-B0D4-46A7-B878-4DAF01FA7A4BQ37551273-3E424C24-26FD-4C62-9BF5-9A31D328AED8Q38355428-F0AE6388-C60F-4B40-AC6C-0C374B5119ECQ38806908-B173B5C3-006C-42E4-98BE-0C39BFE7DE2AQ38858200-5FFB8DA6-6409-4BFE-ABEC-74E5C0D808FAQ39861416-474A21E5-AC27-45EA-AE70-16911A50308FQ40704758-D7D784E1-AEBF-4507-9B37-499263ED96A8Q40900011-EE58835F-E002-4C33-A0D6-55E9B3ACE9CDQ41462915-3C36B75F-CF9E-4A34-94BE-4DB80C313EC4Q41495186-7DF36727-4CE9-464D-B148-22E6CACC2A37Q41986881-302CD4DE-E54D-4C1B-8612-FB9C1B236EF7Q47098470-3358530F-5B20-41CE-A0E0-B57D55560B9AQ47107035-BC66C0F2-37D5-4EF7-BF97-09F6F8EC24ADQ47207269-0B9336A9-99C7-4831-9650-FA1E13A80E4EQ47365813-136EAA9C-10CC-4D36-96E0-DE9279096886Q47579460-D4259453-132F-4309-B61E-5F64FAD48E23Q47630148-4837FF88-2BB6-4699-8CD2-DF55A19DA7B1Q48474125-FE49E126-513F-4DAC-92E4-B152DBF6D5A5Q53514987-796AFB76-77A3-44E8-B389-6EFF8D1A2AA6Q54214638-BB756767-A067-47EB-87EB-CE2F59F0708DQ55019043-1E06A492-D71A-48EE-AEDA-86E722252E2BQ60682620-2E932976-1027-4F1A-89BB-6DF430F92872Q60682621-0CDC5199-356F-451A-A2F5-BA33EBB3C233Q62082746-84813F3E-4230-4F18-9019-56144E87C830Q64097596-9D968AF4-C84A-4024-B790-6E44AC8BAB76Q82831094-BCABEE3C-818C-4F77-95C7-16612ADADD4FQ86453281-1C891247-F45A-4637-8617-D45F523425F2Q89860413-6E382AC0-8614-4E8D-B331-CCE941E3607EQ90062767-F00C10CF-CA60-472D-B67E-D388D4386E3CQ90658902-A9AF1243-A241-46A3-BFB4-21C29A8673B4Q90690586-32B95EBF-97EA-4310-B4EA-A0CE62C52D88Q91030452-CB4A47C9-5B69-409C-BE5C-019909A700CCQ91234132-0356EC8E-8AE4-4CAE-9627-F4A8762C635EQ91496599-31A37F5E-6CDE-48D3-B62F-A100EA0A5767Q91553996-62F56677-3AD4-47FC-988A-340E9FEB5592Q92183469-6F388067-08FE-418C-9231-564BC14B9998Q92185486-2A70D47D-6D08-47A8-9A06-7BB1EF8A7243Q93389769-80A9EF2D-6793-42F4-A873-61423CBA38B2Q94949860-FDEDFE03-BD14-414F-B86B-7C7E1D8A2B9E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jussi Posti
@ast
Jussi Posti
@en
Jussi Posti
@es
Jussi Posti
@nl
Jussi Posti
@sl
type
label
Jussi Posti
@ast
Jussi Posti
@en
Jussi Posti
@es
Jussi Posti
@nl
Jussi Posti
@sl
prefLabel
Jussi Posti
@ast
Jussi Posti
@en
Jussi Posti
@es
Jussi Posti
@nl
Jussi Posti
@sl
P108
P106
P31
P496
0000-0002-5925-5193